3 withdrawn, 1 unknown. 2 Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 1, Withdrawn 1 |
| Not applicable | 1 | Withdrawn 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow 2,4,6-tribromophenol: new trials by email Literature Review of 2,4,6-tribromophenol trials Research Report on 2,4,6-tribromophenol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients Bacteriophage cocktail spray, Xeroform - Wound Infection | Phase 1 | Unknown | Precisio Biotix Therapeutics, Inc. | 12 | 2022-01-01 | 2021-12-22 |
| A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites Tegaderm™(Absorbant, 3M), OASIS® wound matrix, Xeroform™ - Skin Graft Complications | Phase 4 | Withdrawn | Loma Linda University | 2016-10-01 | 2016-12-16 | |
| The Burn Glove Trial - Hand Burn Dressing Pilot Aquacel® Ag Burn Glove, Mepilex® Transfer Ag, antibiotic - Burns | Not applicable | Withdrawn | Southern Illinois University | 2015-12-01 | 2016-07-21 | |
| Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds bacitracin/xeroform, Polymem - Burns | Phase 1 | Withdrawn | MetroHealth Medical Center | 2006-10-01 | 2017-09-11 |
Burns (3) · Bacterial Infections (1) · Cicatrix (1) · Infections (1) · Pseudomonas Infections (1) · Staphylococcal Infections (1) · Wound Infection (1)
Loma Linda University (1) · MetroHealth Medical Center (1) · Precisio Biotix Therapeutics, Inc. (1) · Southern Illinois University (1)
United States (2)
Charles Yowler, MD (1) · Hahns Kim, MD (1) · Nada N Berry, MD (1) · Nancy Tawil, PhD (1) · Subhas Gupta, MD, PhD (1)